Combined supplementation with hesperidin, phytosterols and curcumin decreases adiposity and improves metabolic health in ovariectomized rats

Julio Baudin,Julia Hernandez-Baixauli,Sergio Quesada-Vázquez,Francisca Mulero,Francesc Puiggròs,Lluís Arola,Antoni Caimari

DOI: https://doi.org/10.1039/d3fo05122f

IF: 6.3173

2024-04-11

Food & Function

Abstract:In recent years many women have looked for alternative therapies to address menopause. Hesperidin, phytosterols and curcumin are bioactive compounds that can ameliorate some cardiovascular risk factors associated with menopause, although there are no data concerning the effects of their combined supplementation. We used ovariectomized (OVX) rats, a postmenopausal model with oestrogen deficiency, to evaluate whether supplementation with a multi-ingredient (MI) including hesperidin, phytosterols and curcumin for 57 days would display beneficial effects against fat mass accretion and metabolic disturbances associated with menopause. Twenty OVX rats were orally supplemented with either MI (OVX-MI) or vehicle (OVX). Furthermore, 10 OVX rats orally received the vehicle along with subcutaneous injections of 17β-oestradiol biweekly (OVX-E2), whereas 10 rats were sham operated and received oral and injected vehicles (control group; SH). MI supplementation partly counteracted the fat mass accretion observed in OVX animals, which was evidenced by decreased total fat mass, adiposity index, the weight of retroperitoneal, inguinal and mesenteric white adipose tissue (MWAT) depots and MWAT adipocyte hypertrophy. These effects were accompanied by a significant decrease in the circulating levels of leptin and the mRNA levels of the fatty acid uptake-related genes Lpl and Cd36 in MWAT. These results were very similar to those observed in OVX-E2 animals. OVX-MI rats also displayed a higher lean body mass, lean/fat mass ratio, adiponectin-to-leptin ratio and insulin sensitivity than their OVX counterparts. Our findings can pave the way for using this MI formulation as an alternative therapy to manage obesity and to improve the cardiometabolic health of menopausal women.

biochemistry & molecular biology,food science & technology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate whether a multi - component supplement (a combination of hesperidin, phytosterols and curcumin) can counteract the increase in fat mass and metabolic disorders caused by estrogen deficiency due to ovariectomy. Specifically, the researchers used ovariectomized rats as a model of post - menopausal estrogen deficiency to evaluate whether the oral supplementation of this multi - component supplement within 57 days could have a beneficial effect on menopausal - related fat accumulation and metabolic disorders. In addition, the study also compared the effects of this multi - component supplement with 17β - estradiol (a substance similar to hormone replacement therapy).

Through a series of experiments, such as body composition analysis, indirect calorimetry, oral glucose tolerance test, micro - computed tomography, etc., the paper evaluated the effects of the multi - component supplement on fat mass, body composition, insulin sensitivity, bone density, etc. The research results show that the multi - component supplement can partially counteract the fat accumulation in ovariectomized rats, reduce the total fat mass, fat index, the weight and cell hypertrophy of white adipose tissue (especially mesenteric white adipose tissue), and at the same time increase the proportion of lean body mass, the lean/fat ratio, the adiponectin/leptin ratio and insulin sensitivity. These effects are similar to those in rats receiving 17β - estradiol treatment, indicating that the multi - component supplement may become an alternative therapy for managing obesity in menopausal women and improving their cardiometabolic health.